Our previous studies suggested that Chr-A downregulates protein kinase B (Akt)/glycogen synthase kinase 3 β (GSK-3β) and the downstream c-Myc to inhibit the growth of glioma cells in vivo [28] and in vitro [29]. This evidence concerns the gene MYC and glioma.